Eduardo Durán-Jara

7PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer geneticsAdditive manufacturingPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 15, 2026
Correction: Garrido et al. NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells. Int. J. Mol. Sci. 2020, 21, 7657.

|Aug 27, 2025
Towards Personalized Precision Oncology: A Feasibility Study of NGS-Based Variant Analysis of FFPE CRC Samples in a Chilean Public Health System Laboratory.

Eduardo Durán-Jara, Iván Ponce, Marcelo Rojas-Herrera

|Jul 13, 2024
ADAR-Mediated A>I(G) RNA Editing in the Genotoxic Drug Response of Breast Cancer.

Yanara A Bernal, Eduardo Durán, Isidora Solar

|Dec 09, 2023
Prostaglandin E2 Exposure Disrupts E-Cadherin/Caveolin-1-Mediated Tumor Suppression to Favor Caveolin-1-Enhanced Migration, Invasion, and Metastasis in Melanoma Models.

Lorena Lobos-González, Lorena Oróstica, Natalia Díaz-Valdivia

|Sep 09, 2023
EV-miRNA-Mediated Intercellular Communication in the Breast Tumor Microenvironment.

Francisca Sepúlveda, Cristina Mayorga-Lobos, Kevin Guzmán

|Apr 12, 2022
Lactadherin: From a Well-Known Breast Tumor Marker to a Possible Player in Extracellular Vesicle-Mediated Cancer Progression.

Eduardo Durán-Jara, Tamara Vera-Tobar, Lorena De Lourdes Lobos-González

Pageof 2

Frequent Collaborators

3 joint publications

Lorena Oróstica

3 joint publications

Lorena Lobos-González

2 joint publications

Jonás Chnaiderman

2 joint publications

Manuel Valenzuela-Valderrama